This post was originally published on this site
While investing in value stocks is one of the best strategies now, finding quality value stocks in the high-trading market isn’t easy. According to a CNBC survey, nearly 70% of the respondents said that value stocks would do better than their growth counterparts in the coming months.
Despite performing well over the past few months, shares of Bristol-Myers Squibb Company (NYSE:BMY), PetroChina Company (OTC:PCCYF) Limited (PTR), and Gilead Sciences, Inc. (NASDAQ:GILD) still look undervalued at their current price levels, considering these companies’ growth prospects. In addition, our proprietary POWR Ratings system has rated these stocks A for Value along with an overall Strong Buy or Buy rating.
